• Skip to main content

Allergy Partners

  • Find a New Location
  • Patient Portal
  • Bill Pay
  • Become an Allergy Partner
  • Site Search
  • Providers
  • Services
        • Treatment
          • Allergy Shots
          • Biologics
          • Medications
          • Food Allergy Risk Reduction (FARR®)
          • Food Oral Immunotherapy (Food OIT)
          • Food Sublingual Immunotherapy (Food SLIT)
          • Environmental Sublingual Immunotherapy (Environmental SLIT)
        • Testing
          • Blood Testing
          • Food Allergy Testing
          • Patch Testing
          • Pulmonary Function Testing
          • Restech Testing
          • Skin Testing
  • Conditions
        • Food/ Gastrointestinal
          • Eosinophilic Esophagitis
          • Food Allergies
          • Laryngopharyngeal Reflux Disease
        • Lung
          • Asthma
          • Chronic Cough
        • Nasal, Sinus, Eye
          • Environmental Allergies
          • Eye Allergies (Allergic Conjunctivitis)
          • Nasal Polyps
          • Sinusitis
          • Vasomotor Rhinitis/ Chronic Rhinitis
        • Other Conditions
          • Anaphylaxis
          • Immune Deficiency
          • Medication Allergy
          • Recurrent Infections
          • Stinging Insect Allergy
          • Pediatric Allergies
        • Skin
          • Angioedema
          • Contact Dermatitis
          • Eczema (Atopic Dermatitis)
          • Hives/Urticaria
          • Latex Allergy
          • Metal Allergy
  • About Us
        • About Us
        • Blog
        • Careers
        • Clinical Research
        • Pharmacy
        • What Is an Allergist?
  • Patient Resources
        • Pathway to Relief
        • Patient Portal
        • Bill Pay
        • Video Center
        • New Patient Forms & Resources
        • Request Medical Records
        • Patient Rights
        • Notice of Privacy Practices
  • Find a Location

Search Results for:

Are Nasal Sprays Addictive?

February 13, 2023 by

Home / Search for ""
previous post

next post

by Allergy Partners
February 13, 2023

Are Nasal Sprays Addictive?

man crying

Allergy Partners’ Myth Busters Investigate

It’s natural to be concerned about taking any medication consistently, but this worry can be especially pronounced when dealing with nasal sprays. There have been some articles circulating lately claiming that these treatments are addictive, so it is understandable why you may feel hesitant or overwhelmed. Rest assured: you do not need to fear powerful decongestants and allergy medicines! In fact, treating your symptoms properly using prescription-strength medications can greatly reduce your suffering – without risking addiction.

Rebound Effect Vs. Addiction

What many patients are referring to when talking about getting addicted to nasal sprays is not addiction, but a rebound effect from using these types of decongestant medications. If used for more than five days straight, your body may become less responsive and require higher doses in order to reduce congestion. Luckily there’s an easy way around this: alternate every day between medications like antihistamines or even saline solutions so that you can avoid getting stuck with symptoms again.

Relief from allergies is possible with the daily use of nasal steroids or antihistamine sprays. Both prescription and over-the-counter formulations are available for safe, long-term symptom control. Your Allergy Partners allergist can help determine what treatment method works best for your specific allergy needs so that you can breathe easily again.

Alternatives to Nasal Sprays

Allergy nasal sprays are the most common treatment for allergies and they can be helpful in providing relief from congestion, nasal itching, sneezing, and other allergy symptoms. However, there are alternative options available to those who do not wish to use these prescription medications. Antihistamines taken orally are a great alternative for treating allergies and can provide quick relief of symptoms.

Nasal irrigation with a neti pot or saline spray is also an effective treatment for relieving congestion caused by allergies. Additionally, natural herbal remedies such as stinging nettle or butterbur have been used as traditional treatments for allergies and may offer some relief without many of the side effects associated with medication.

Allergy Myth: Busted!

Fear not, the myth of addictive nasal sprays has been DEBUNKED! But beware, overusing those decongestant sprays can have you trapped in a congestion cycle. Fear not, your trusty Allergy Partners physician is ready to recommend the ideal allergy treatments tailored just for you.

Find Answers at Allergy Partners

Whether you’re dealing with seasonal or chronic allergies, the team at your local Allergy Partners can help you better understand what is bothering you and help you find some relief. We take the time to learn about your experience so that we can personalize a treatment plan that perfectly targets your needs.

Find a location near you to schedule an appointment with our premier allergists today – they’re backed by Allergy Partners’ national network of board-certified physicians. Relief from symptoms is closer than you think.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Resources

COVID Vaccine FAQ

February 12, 2023 by

Home / Search for ""
previous post

next post

by Allergy Partners
February 12, 2023

COVID Vaccine FAQ

Celebrating No COVID

The doctors at Allergy Partners have been following the pandemic, including vaccine development, testing and distribution closely on your behalf. The approval of the first COVID-19 vaccines by Pfizer and Moderna has been met with enormous public interest and generated a lot of questions and we’d like to answer some of them here:

Who should get the vaccine?
• Almost all adults should get vaccinated

Can children get the current vaccines?
• No vaccine has yet been approved for children under 16 and children should not be vaccinated until studies are complete and a vaccine has been approved for their age group.

Can people with immune deficiencies get the vaccine?
• Because there are more than 450 immunodeficiencies, it is not possible to make a blanket recommendation, but, because none of the vaccines are live, there is no additional risk to immunodeficiency patients.
Because it appears that most immunodeficiency patients infected with coronavirus have not had serious COVID-19 disease, primary immunodeficiency may not be considered a high-risk condition in your state.

Can people with asthma get the vaccine and are they considered at particular risk for serious COVID-19?
• Yes, people with asthma can receive the vaccine. At this time, the best evidence available is that people with asthma, except for some with very severe asthma, are not at increased risk for serious COVID-19 disease and, therefore, are not in a high-risk group.

Do the vaccines work?
• Yes. Extensive clinical trials show that the approved vaccines are clearly effective. Both have been shown to be 94-95% effective in preventing the spread of COVID-19.

Is one vaccine better than another?
• There are more vaccines coming but we don’t know their study results yet. At this time, there is no basis to prefer one vaccine over another.

Are the vaccines safe?
• Yes. Based on tens of thousands of vaccine recipients, the vaccines are safe As with any new medication, some very rare side effects may only be detected when large numbers of people have been vaccinated. There will be continued close monitoring of the safety of these new vaccines over time.

Are there side effects from the vaccine?
• As with all vaccines, rare side effects have occurred. The information about the vaccine reactions is limited but it is likely that some are allergic reactions and some are not.

Can the vaccines cause allergic reactions?
• Rare cases of allergic reactions to have been reported. There is a suspicion that an additive, polyethylene glycol, has triggered at least some of the allergic reactions. Allergy to polyethylene glycol is rare.

If I have had food, stinging insect, medication allergies or hay fever, can I get the vaccine?
• Yes. People with these types of allergy can receive the vaccine, but should be monitored after the vaccine for at least 15 minutes after the vaccine.

If I have had an allergic reaction to other vaccines, can I receive the COVID vaccine?
• Likely yes, but individuals who have previously experienced vaccine reactions should consult with their allergist about where to receive their vaccine and be monitored for at least 30 minutes after the vaccine

Where can I learn more about allergies and the vaccine?
• Go HERE

If I get the COVID vaccine, when can I get my allergy shots?
• While there is no data on this, our recommendation is to receive you not receive your allergy shot and COVID vaccine at least one day apart.

How will the vaccine be distributed?
• Distribution of the vaccine will vary by state. Be sure to check your state health department’s web site for information

When will everyone have access to the vaccine?
• It is unlikely that vaccine will be available for the general public until March or April

For more information, please see this post from Johns Hopkins University. As things are changing so rapidly, we will update you as new information becomes available.

By: Dr. Richard Wasserman

Allergy Partners of North Texas

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Resources

Allergy Fellows: It’s never too early to start your job search

February 9, 2023 by

Home / Search for ""
previous post

next post

by Allergy Partners
February 9, 2023

Allergy Fellows: It’s never too early to start your job search

woman typing on computer

Allergy practices commonly plan for new providers at least a year in advance. Making inquiries early gives both parties ample opportunity to make a good match.

Starting your post-fellowship career planning, even in the first year of your program, can ensure that your dedication is rewarded with a placement ideal for you and your family.

Most physicians, as they work through residency and fellowship, have a good idea about where they would like to build their careers. Whether it’s a hometown or favorite destination, the magic happens when that desire aligns with market factors and, ideally, a practice looking to add a physician to your timeline. Many practices have 3-5 year plans that identify key growth markets, as well as locations where a new physician should be added to keep up with demand or to replace physicians planning to retire.

In other words, your post-fellowship job might already be out there.

Start Looking for Allergy and Immunology Jobs

Ideally, you should begin reaching out in your first year or second year of fellowship, although there’s no harm in starting to form relationships with your target practices even earlier.

  • Start the conversation by attending Academy and College meetings and stopping by booths on the exhibitor floor. Practice representatives will be able to share early growth plans in the areas in which you’re interested and can even put you in touch with physician ambassadors already in practice there.
  • Attend virtual and in-person career fairs specific to allergists.
  • Keep an eye on the Academy and College job boards and set alerts for your favorite locations.
  • Search the internet and bookmark target practices.
  • Follow practices on LinkedIn and other social media platforms.
  • Reach out to physicians that you know and ask them about their experience with their practice. Would they recommend it?
  • Introduce yourself to physicians in your target area and ask if they’d let you shadow. Tell them your plans and ask for their advice. They might have plans to add a physician that matches your timeline.

Know the Timelines

The interview, negotiation, and contracting timeline varies by practice, but most would agree that a compact and meaningful process is best for all parties. You should expect a timely response from a practice with which you’re interviewing but understand that the complexities of a larger practice might add to the turnaround time.

If you are applying for a job that has already been identified by the practice, the entire process should take about 8-12 weeks from the first conversation to a fully executed contract. Salary and other negotiations will add to this timeline. If you are reaching out to a practice early in your fellowship, you should expect to be in conversation with them for a year or more. However, once an opportunity has been identified, a practice may be comfortable signing a contract a year in advance of your start date. You can then focus solely on your studies for the remainder of your program.

Licensing and credentialing add a few months to the post-contract process. It’s a good idea to apply for your state license while you’re still in early conversation with a practice because credentialing with payors cannot begin until a state license is received and can commence only after July 1 following completion of your fellowship. From that point, the process takes 90-120 days to be fully credentialed with payors. That puts most physicians coming out of fellowship on track to start seeing patients about October.

Keeping in Touch

Larger practices will have a system of tracking candidate interest, but don’t be afraid to check in periodically. If you’re early in a search and your plans change, let practices with whom you’ve been in contact know that you are looking at different options or locations. They will appreciate the communication.

At Allergy Partners, our director of recruiting maintains a database that cross-references candidate interest with our growing footprint. We love to speak with Fellows early in their program so that we can identify and align potential synergies between candidates and our growth initiatives. In many situations, we’re able to complete the interview process well in advance of graduation (as much as a year) so that you can focus your attention on your training, knowing you have a job waiting for you.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Pathway to Partnership

Do Inhaled Corticosteroids (ICS) Stunt Growth?

January 20, 2023 by

Home / Search for ""
previous post

next post

by Allergy Partners
January 20, 2023

Do Inhaled Corticosteroids (ICS) Stunt Growth?

Young girl playing in field

Our Myth Busters Investigate

The question about corticosteroids (think inhalers) and their impacts on growth is an important one for our patients and parents. For many years, there has been concern over whether or not inhaled corticosteroids (ICS) – drugs taken to treat asthma and related respiratory disorders – may have potential side effects leading to delayed or stunted childhood growth.

Research has revealed that the use of ICS (inhalant corticosteroids) in children with asthma can have a slight but measurable negative impact on linear growth, weight gain, and skeletal maturation. It is recommended that minimal doses be used to avoid any potential adverse effects; however, further research shows asthmatic females and those tested positively for skin allergies are especially vulnerable to diminished growth when using these medications. The initial onset of decreased growth appears after one year without increased risks over time.

Recent studies have also revealed that intermittent use of ICS and intranasal steroids can be just as effective in treating asthma, yet with a significantly lower overall dose. This suggests an important opportunity for more targeted treatments to help children manage their asthmatic symptoms while minimizing negative growth effects.

Asthma Myth: Confirmed!

It’s encouraging to know that modern medical treatments such as inhaled and intranasal corticosteroid medications can help treat the symptoms of asthma in adults, even if their use may be associated with a slight decrease in overall height. The positive impact these medications have on managing asthma should never be underestimated. Not only do they provide relief from acute symptoms, but also reduce the likelihood of future attacks. For those who require regular treatment to manage the condition, there is undeniable peace of mind that comes with having access to these medications and their proven benefit of maintaining asthma control.

Contact Allergy Partners to Learn More

At Allergy Partners, our network of board-certified allergists are here for you, expertly diagnosing asthma and allergic conditions and formulating personalized treatment plans that work with your lifestyle while monitoring growth over time. Your health and wellness are our physicians’ top priority. If asthma is slowing you down, relief is in sight when you have our experienced professionals on your side.

Learn more about dealing with asthma and then find your nearest Allergy Partners office to schedule an appointment!

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Resources

Allergy Myth Busters: Is All Immunotherapy the Same?

December 20, 2022 by

Home / Search for ""
previous post

next post

by Allergy Partners
December 20, 2022

Allergy Myth Busters: Is All Immunotherapy the Same?

Allergenic Extract

Inspired by one of our favorite television shows, Allergy Myth Busters looks at a number of popularly held beliefs about allergy. But are these myths just urban legends or are they true?

MYTH: All immunotherapy is the same

THE BACKGROUND: Immunotherapy (also known as allergy shots) is an effective treatment for allergic nasal and eye symptoms (allergic rhinitis and allergic conjunctivitis), allergic asthma, and eczema. Immunotherapy can also be used to treat stinging insect allergies. Small amounts of the allergen (the substance that patients are allergic to) are injected in regular intervals over several years to desensitize patients to those substances. Immunotherapy is designed to alleviate current symptoms as well as prevent the progression of allergic disease. Relief of symptoms also continues after allergy shots are stopped making it a cost effective and beneficial treatment for many allergy sufferers. Several people and even physicians believe that all immunotherapy is the same.

THE SCIENCE: Not all allergen immunotherapy is created equally.

Allergy testing identifies specific allergies in each patient. Small amounts of these allergens are then combined to make allergy shots. Immunotherapy is tailored specifically for each patient based on their degree of allergies and underlying disease. Current medications and other coexisting diseases should also be taken into account when formulating the strength of these extracts. If the dose of allergen included in the allergy shots is too weak, the patient will not mount an effective or long lasting immune response. If the dose of allergen in the allergy shots is too strong, the patient will have increased risk of an allergic reaction or adverse reaction to the shots.

Board certified allergists are specialists who have performed the highest level of education based on national standards for the field of allergy and immunology. They are extensively trained on doses and concentrations of allergens that are the most effective and safe. They are also trained on specific allergens that are more prominent in their local area and are aware of any cross reactivity between allergens that might affect your treatment response. Here at Allergy Partners, our providers have many years of experience in formulating allergen immunotherapy, and our immunotherapy program is the nation’s largest. Our physicians continuously review studies and safety data to determine the most up to date recommendations on the safest and most effective allergen dosing for allergy shots.

THE VERDICT: The Myth that all allergen immunotherapy is the same has been busted.

Ingrid Hoffmann, MD
Allergy Partners of the Piedmont

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Allergy Shots

Allergy Partners Announces Collaboration With Aimmune Therapeutics

November 29, 2022 by

Home / Search for ""
previous post

next post

by Allergy Partners
November 29, 2022

Allergy Partners Announces Collaboration With Aimmune Therapeutics

Allergy Partners

Allergy Partners Announces Collaboration With Aimmune Therapeutics to Provide Palforzia® [Peanut (Arachis Hypogaea) Allergen Powder-DNFP] Directly to Patients

Collaboration strengthens patient access to PALFORZIA through Allergy Partners’ national network of specialty practices

Children and teenagers aged 4 through 17 years with a confirmed diagnosis of peanut allergy to benefit from direct access to high-quality treatment and improved specialty care

Important step forward for Allergy Partners, less than one year after its strategic partnership with B-Flexion, the long-term investor in the allergy sector

ASHEVILLE, N.C. & BRISBANE, Calif.–(BUSINESS WIRE)–Allergy Partners, the nation’s largest single specialty allergy practice group leading the development and delivery of high-quality health care for patients with asthma and allergic disease, today announced a strategic collaboration with Aimmune Therapeutics, Inc., a Nestlé Health Science company developing pharmaceutical therapies to prevent, manage, and treat food, gastrointestinal, and metabolic-related diseases, to provide Allergy Partners’ patients aged 4 through 17 years with a confirmed diagnosis of peanut allergy with direct access to PALFORZIA, the first and only FDA-approved peanut allergy treatment.

PALFORZIA was approved in January 2020 by the U.S. Food and Drug Administration (FDA) as an oral immunotherapy (OIT) for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut in patients aged 4 through 17 years with a confirmed diagnosis of peanut allergy. It is not indicated for the emergency treatment of allergic reactions, including anaphylaxis. PALFORZIA is to be used in conjunction with a peanut-avoidant diet.

Allergy Partners’ nation-wide care network provides high-quality health care for patients with asthma and allergic diseases, promoting education, research, and innovation in the field. As a result of this collaboration, Allergy Partners will begin to provide PALFORZIA directly to patients through its specialty pharmacy, Allergy Partners Therapeutics (APT), across its entire national network of 64 practices and 126 community locations in 19 states.

“Supported by the recent strategic investment from B-Flexion, our commitment will continue to be to provide the best possible care to our patients and improve health outcomes across an expanding allergy network, and this unique collaboration with Aimmune will enable us to improve patient access to this important treatment through APT and our network of dedicated providers,” said Dr. Bill McCann, Chief Medical Officer of Allergy Partners. “We are pleased to be working with Aimmune, which is at the forefront of developing allergy therapies like PALFORZIA that have the potential to help transform the lives of patients that often have few or no treatment options available to them.”

“PALFORZIA is an important treatment option for patients living with peanut allergy, helping to reduce the risk of severe allergic reactions due to accidental exposure, and enabling them to live with fewer restrictions,” said Andrew Oxtoby, President and CEO, Aimmune Therapeutics. “Aimmune is committed to help ensure that all eligible patients who wish to access PALFORZIA are able to do so, and the announcement today of our collaboration with Allergy Partners marks another step toward that goal.”

Please see the below Important Safety Information or visit www.PALFORZIA.com for the full Prescribing Information, including Boxed WARNING and Medication Guide.

What Is PALFORZIA?

PALFORZIA is a treatment for people who are allergic to peanuts. PALFORZIA can help reduce the severity of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut. PALFORZIA may be started in patients aged 4 through 17 years old. If you turn 18 years of age while on PALFORZIA treatment you should continue taking PALFORZIA unless otherwise instructed by your doctor.

PALFORZIA does NOT treat allergic reactions and should not be given during an allergic reaction.

You must maintain a strict peanut-free diet while taking PALFORZIA.

Important Safety Information

PALFORZIA can cause anaphylaxis which may be life-threatening. You will receive your first dose in a healthcare setting under the observation of trained healthcare staff.

You will receive the first dose of all dose increases in a healthcare setting.

In the healthcare setting, you will be observed for at least 1 hour for signs and symptoms of a severe allergic reaction.

If you have a severe reaction during treatment, you will need to receive an injection of epinephrine immediately and get emergency medical help right away.

You will return to the healthcare setting for any trouble tolerating your home doses.

Stop taking PALFORZIA and get emergency medical treatment right away if you have any of the following symptoms after taking PALFORZIA:

  • Trouble breathing or wheezing
  • Chest discomfort or tightness
  • Throat tightness
  • Trouble swallowing or speaking
  • Swelling of your face, lips, eyes, or tongue
  • Dizziness or fainting
  • Severe stomach cramps or pain, vomiting, or diarrhea
  • Hives (itchy, raised bumps on skin)
  • Severe flushing of the skin

Because of the risk of severe allergic reactions, PALFORZIA is only available through a restricted program called the PALFORZIA Risk Evaluation and Mitigation Strategy (REMS) Program. Talk to your healthcare provider for more information about the PALFORZIA REMS program and how to enroll.

You should NOT take PALFORZIA if you have uncontrolled asthma, or if you ever had eosinophilic esophagitis (EoE) or other eosinophilic gastrointestinal disease.

Tell your doctor if you are not feeling well prior to starting treatment with PALFORZIA. Your doctor may decide to delay treatment until you are feeling better. Also tell your doctor about any medical conditions you have and if you are taking or have recently taken any other medicines, including medicines obtained without a prescription and herbal supplements.

Your doctor may decide that PALFORZIA is not the best treatment if:

  • You are unwilling or unable to receive (or self-administer) injectable epinephrine.
  • You have a condition or are taking a medication that reduces the ability to survive a severe allergic reaction.

What are the possible side effects of PALFORZIA?

The most commonly reported side effects of PALFORZIA were: stomach pain, vomiting, feeling sick, itching or burning in the mouth, throat irritation, cough, runny nose, sneezing, throat tightness, wheezing, shortness of breath, itchy skin, hives, and/or itchy ears.

PALFORZIA can cause anaphylaxis which may be life-threatening. PALFORZIA can cause stomach or gut symptoms including inflammation of the esophagus (called eosinophilic esophagitis). Symptoms of eosinophilic esophagitis can include:

  • Trouble swallowing
  • Food stuck in throat
  • Burning in chest, mouth, or throat
  • Vomiting
  • Regurgitation of undigested food
  • Feeling sick

For additional information on the possible side effects of PALFORZIA, talk with your doctor or pharmacist.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

About Allergy Partners

Allergy Partners, PLLC which in December 2021 received a strategic investment from B-Flexion, the private investment firm managing funds on behalf of the Bertarelli Family, is the largest single specialty practice group, and recognized as leaders in the development and delivery of high-quality health care for patients with asthma & allergic disease. Our vast care network of providers works together to promote education, research & innovation in the field of allergy & asthma care. Learn more about www.allergypartners.com

About Aimmune Therapeutics

Aimmune Therapeutics, part of Nestlé Health Science, is a biopharmaceutical company that aspires to be a global leader in developing innovative medicines to prevent, manage, and treat food, gastrointestinal (GI), and metabolic-related diseases for those with few or no treatment options. Aimmune was built on the belief that families deserve standardized, regulatory-approved, science-driven treatments that reduce their daily burden and help them better manage these conditions.

For more information about Aimmune, please visit www.aimmune.com

Contacts

Blair Hennessy, Abernathy MacGregor
(212) 371-5999 / bth@abmac.com

Georgina Vincent, Head of External Communications
(747) 758-9524 / gvincent@aimmune.com

https://www.businesswire.com/news/home/20221013006052/en/

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: News

Back-to-School: Basics for Kids with Allergies

August 15, 2022 by

Home / Search for ""
previous post

next post

by Allergy Partners
August 15, 2022

Back-to-School: Basics for Kids with Allergies

Young Girl Smiling at Doctor

The following guide offers strategies for managing your child’s allergies during the school year.

Managing a child’s allergies is challenging enough when they’re at home – how can you make sure they’re protected during the school day?

Whether your child has food allergies, insect sting allergies, asthma, or another allergy that requires vigilant management, it’s critically important that you use every resource available to you. Here’s how you can ensure your child has a safe and welcoming school year.

Recognize Allergy Signs

Schedule an appointment with your allergist or pediatrician if your child experiences the following symptoms:

  • Frequent respiratory symptoms (itchy eyes, runny nose, sneezing , coughing, wheezing, shortness of breath)
  • Frequent infections (ear, sinus, bronchitis, pneumonia) Changes in skin texture or appearance (rashes, dry patches, hives)

During your visit, the physician will conduct a physical examination and evaluate your child’s symptoms. You will be asked about your child’s dietary habits, environment, and medical history. Your physician will recommend allergy testing or not based on the information provided. If allergy testing is recommended, request a referral to a board-certified allergist.

Your allergist will provide you with instructions to help you prepare for testing. These instructions are designed to maximize the accuracy of the testing and might include the following guidance:

  • Don’t administer antihistamines the week before the test.
  • Avoid any substances that trigger physical symptoms before the test.

Allergy testing might involve the following:

  • Skin Prick Test: Skin prick testing involves introducing a small sample of allergen proteins to the child’s skin and then gently pricking or scratching the skin’s surface. If the child is allergic to a particular substance, inflammation or redness may develop.
  • Blood Test: During immunoglobulin E (IgE) sensitization testing, a blood sample is taken and then analyzed to identify specific antibodies related to different allergens. This type of test is preferred for children who cannot undergo skin prick testing.

The test results will identify any allergens that cause the reaction. Your allergist will explain the test results to you and help you develop an appropriate management plan and emergency action plan.

Create a Management Plan With Your Child’s Allergist

It’s critically important to create a comprehensive allergy management plan if your child is experiencing symptoms that are either disruptive to normal functioning or potentially life-threatening. While management plans must be specific to the child and the type of allergy, they will include the following strategies:

  • Procedures for avoiding allergens.
  • Managing symptoms through medications, diet, or other therapies.
  • Scheduling periodic follow-ups with allergy specialists to monitor the symptoms and adjust medications/therapies as needed.
  • Design an emergency action plan for addressing dangerous allergic responses, including the proper use of epinephrine injectors (EpiPens).

Communicate With Your Child’s Teachers and Appropriate School Staff

Clear communication and collaboration are critical to ensuring your child’s safety and comfort during the school year.

  • Alert your school and school district to your child’s condition: While school districts throughout the United States have different administrative processes, they will generally allow you to access or fill out the necessary documents online. However, whether they require you to visit the enrolment offices or submit the paperwork electronically, always keep digital or physical copies of any paperwork you submit for your own records.
  • Have a meeting with school staff: Communicating your child’s needs with teachers, administrators, and school nurses is essential to creating and maintaining a safe and inclusive school environment. If possible, meet with all staff members who will come in contact with your child, including counselors, homeroom teachers, school mental health aides, and security personnel.
  • Share your allergy action plan with school staff: Collaborating with the child’s healthcare provider, parents can develop an allergy action plan that provides specific steps to be taken during an allergic reaction. This plan should include information about recognizing signs, administering emergency medication, and contacting emergency services if necessary. Sharing this plan with the school staff ensures everyone is prepared to respond appropriately. Moreover, clarify how epinephrine injectors can be easily accessed in case of an allergic reaction or where emergency medication should be stored. It is crucial to establish clear protocols for medication storage and accessibility.
  • Ask to review training records for epinephrine injectors and other interventions: Make sure that every adult that comes in contact with your child can recognize the onset of an allergic response and can intervene appropriately and quickly.

Different Types of Allergies Will Require Different Strategies and Accommodations

Anaphylaxis

Anaphylaxis is an extreme and potentially fatal allergic response. It develops due to an overreaction of the immune system to a substance it perceives as harmful. The most common substances that trigger anaphylaxis are insect venom, certain foods (like peanuts, tree nuts, sesame seed, seafood, milk, and eggs), latex, and medications.

The symptoms of anaphylaxis can occur suddenly and can involve numerous organ systems. The condition is considered a medical emergency requiring immediate intervention. When untreated, anaphylaxis can be life-threatening..

Schools can reduce the risk of anaphylaxis in the following ways:

  • Maintain strict protocols surrounding access to emergency medications like epinephrine injectors.
  • Provide staff-wide training in emergency treatment administration.
  • Provide student training in emergency treatment administration.
  • Provide staff-wide training in recognizing anaphylaxis symptoms.
  • Provide student training in recognizing anaphylaxis symptoms.
  • Make epinephrine injectors easily accessible.
  • Allow students to carry their own prescribed epinephrine injectors.

Food Allergies

Food allergies are becoming increasingly common among children; nearly 6% of children experience food allergies, according to the Centers for Disease Control and Prevention.

A food allergy is a type of immune system response triggered by particular foods. When someone has a food allergy, their immune system misidentifies certain proteins in the food as dangerous and overreacts to them.

Common food allergy symptoms include abdominal discomfort, diarrhea, nausea, vomiting, hives, itching, swollen lips, swollen tongue, and swollen throat. In more serious instances, food allergies can cause anaphylaxis, a potentially deadly reaction.

Schools can accommodate children with food allergies in the following ways:

  • Institute allergy-aware policies in the classrooms.
  • Establish a safe cafeteria environment.
  • Inspect food item ingredient lists regularly.
  • Maintain open communication with parents and guardians.
  • Address allergy or food-related bullying immediately.

Stinging Insect Allergies

Hymenoptera venom allergies, commonly known as insect sting allergies, are allergic reactions that occur in response to the venom injected by stinging insects such as honey bees, yellow jackets, hornets, wasp, and fire ants. These allergies can range from mild, localized reactions to severe systemic reactions, including anaphylaxis.

Schools can accommodate children with insect sting allergies in the following ways:

  • Limit exposure to stinging insects by controlling pests in the common outdoor areas.
  • Provide insect-repellant products.
  • Maintain an allergy-aware classroom by limiting flowers and plants that could attract insects.

Asthma

Asthma is a common, chronic respiratory condition that affects millions of people worldwide, both children and adults. The symptoms of asthma can vary from person to person but typically include wheezing, inability to breathe, coughing, and chest tightness.

Asthma and allergies can be interrelated; asthma can be triggered by certain allergens like dust, pet dander, and pollen.

Schools can accommodate children with asthma in the following ways:

  • Offer asthma education and awareness for students and staff.
  • Screen for asthma triggers and maintain a healthy, clean environment.
  • Provide physical education tailored to the needs of students with asthma.

Latex Allergies

Latex allergies are immune system overreactions to natural rubber latex. Latex allergy symptoms can range from minor to life-threatening. They might include skin eruptions (hives, rashes), respiratory symptoms (sneezing, coughing, a runny nose, shortness of breath), or anaphylaxis.

People with severe latex allergies can be put at risk in an environment where latex particulates are in the air.

Latex allergies sometimes correspond with certain food allergies because they share similar protein structures. Foods that frequently trigger allergic responses in people with latex allergies include avocados, bananas, chestnuts, kiwi, potatoes, and tomatoes.

Schools can accommodate children with latex allergies in the following ways:

  • Make sure school supplies, toys, and furnishings are latex-free.
  • Educate administrators, school nurses, and lunchroom staff about products containing latex and alternative, safe materials.

Allergic Rhinitis (Hay Fever)

Allergic rhinitis, known commonly as hay fever, is a common condition that affects nearly 20% of children in the United States. People affected by hay fever experience a disordered immune response when they inhale allergens (dust, pollen, dust mites, mold) through the mouth or nose. Hay fever symptoms include coughing, sneezing, nasal congestion, fatigue, and watery eyes.

Unmanaged hay fever symptoms can significantly affect a student’s ability to succeed in school. Schools can accommodate children affected by hay fever in the following ways:

  • Limit the presence of allergens (pollen, mold, dust, dander) in the classroom and other common areas.
  • Provide the appropriate resources and supplies (tissues, hand wipes) to maximize comfort for students struggling with hay fever symptoms.
  • Modify outdoor physical education and recess activities to minimize exposure to pollen and other allergens.

Discuss Allergy Management With Your Child

Managing significant allergies can be challenging for a child. It’s important to involve your child in the allergy management strategy early so the processes become second nature.

Choose a relaxed and comfortable environment to start a discussion about your allergy management plan. Make sure it is a safe and open space for your child to ask questions and express their concerns. Encourage them to talk about any fears they may have regarding their allergies, and allow them to be as proactive about their allergy management as their age and abilities allow. Reassure them that you are there to support and help them navigate their allergy management effectively.

Allergy Partners Can Help With Your Child’s Allergies

If you have any questions about allergy management or if you would like to schedule an examination with a board-certified allergist, please contact our helpful representatives today.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: Resources

Black History Month 2021 with Dr. Aerik Williams | Podcast

February 1, 2022 by

Home / Search for ""

next post

by Allergy Partners
February 1, 2022

Black History Month 2021 with Dr. Aerik Williams | Podcast

Aerik Williams

It is Black History Month and we have a very special episode to share with you. Allergy Partners’ physician, Dr. Aerik Williams, takes you along on his journey to becoming an allergist and discusses his recently published book. Whether you want to learn more about #racialissuesinhealthcare, are looking for an amazing biography to read, or want to get to know Dr. Williams a little better, this is the podcast for you.

We would like to not only recognize Dr. Aerik Williams, but to also celebrate him and his successes.

Dr. Williams has been with Allergy Partners since 2014. He joined Statesville, NC on 8/15/14 and went solo in Salisbury 1/1/2016. Since then, he has been repeatedly complimented by his staff and patients on his caring personality and professionalism.

In this very special podcast, Dr. Williams covers a wide range of topics from his memoirs, Aerik’s Anatomy, including:

• His personal experiences dealing with racism and stereotypes throughout his life

• Challenges in our healthcare system that are negatively impacting people of color

• His journey to achieve his lifelong goal to become a physician like his father

*Trigger warnings

Mental illness; racism and racial slurs; suicide; miscarriage.

  • Providers
  • Services
  • Conditions
  • About Us
  • Careers
  • Find A Location
  • Patient Resources
  • Become an Allergy Partner
  • Blog
  • Allergy Partners Shop
Allergy Partners Home
  •  

© 2024 All Rights Reserved.

    • Notice of Privacy Practices
    • Patient Rights
    • Site Privacy Policy
    • Site Terms of Use
    • Site Accessibility
    • Site Search
    • Employee Healthcare Info
    • Site Map

Filed Under: News

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 117
  • Page 118
  • Page 119